Selected research
Market Structure
Global Hemostatic Powder Spray Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Hemostatic Powder Spray market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hemostatic Powder Spray include Medtronic, QuikClot, Pfizer Inc., Hemostasis, LLC, Ethicon Inc., EndoClot Plus, Inc, CryoLife, Inc., Cook Medical and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Hemostatic Powder Spray market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hemostatic Powder Spray and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hemostatic Powder Spray sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatic Powder Spray market size, projected growth trends, production technologies, key applications, and end-use industries.
Hemostatic Powder Spray Segment by Company
Medtronic
QuikClot
Pfizer Inc.
Hemostasis, LLC
Ethicon Inc.
EndoClot Plus, Inc
CryoLife, Inc.
Cook Medical
BD
Baxter International Inc.
B. Braun
Advanced Medical Solutions Group
Hemostatic Powder Spray Segment by Type
Less than 50ml
50ml and Above
Hemostatic Powder Spray Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Hemostatic Powder Spray Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Powder Spray market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Powder Spray and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Powder Spray.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hemostatic Powder Spray market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostatic Powder Spray manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemostatic Powder Spray in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hemostatic Powder Spray in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Less than 50ml
- 50ml and Above
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Others
Companies covered
- Medtronic
- QuikClot
- Pfizer Inc.
- Hemostasis, LLC
- Ethicon Inc.
- EndoClot Plus, Inc
- CryoLife, Inc.
- Cook Medical
- BD
- Baxter International Inc.
- B. Braun
- Advanced Medical Solutions Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hemostatic Powder Spray Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hemostatic Powder Spray Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hemostatic Powder Spray Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hemostatic Powder Spray Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hemostatic Powder Spray Market Dynamics
- 2.1 Hemostatic Powder Spray Industry Trends
- 2.2 Hemostatic Powder Spray Industry Drivers
- 2.3 Hemostatic Powder Spray Industry Opportunities and Challenges
- 2.4 Hemostatic Powder Spray Industry Restraints
3 Hemostatic Powder Spray Market by Manufacturers
- 3.1 Global Hemostatic Powder Spray Revenue by Manufacturers (2021-2026)
- 3.2 Global Hemostatic Powder Spray Sales by Manufacturers (2021-2026)
- 3.3 Global Hemostatic Powder Spray Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hemostatic Powder Spray Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hemostatic Powder Spray Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hemostatic Powder Spray Manufacturers, Product Type & Application
- 3.7 Global Hemostatic Powder Spray Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hemostatic Powder Spray Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hemostatic Powder Spray Players Market Share by Revenue in 2025
- 3.8.3 2025 Hemostatic Powder Spray Tier 1, Tier 2, and Tier 3
4 Hemostatic Powder Spray Market by Type
- 4.1 Hemostatic Powder Spray Type Introduction
- 4.1.1 Less than 50ml
- 4.1.2 50ml and Above
- 4.2 Global Hemostatic Powder Spray Sales by Type
- 4.2.1 Global Hemostatic Powder Spray Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hemostatic Powder Spray Sales by Type (2021-2032)
- 4.2.3 Global Hemostatic Powder Spray Sales Market Share by Type (2021-2032)
- 4.3 Global Hemostatic Powder Spray Revenue by Type
- 4.3.1 Global Hemostatic Powder Spray Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hemostatic Powder Spray Revenue by Type (2021-2032)
- 4.3.3 Global Hemostatic Powder Spray Revenue Market Share by Type (2021-2032)
5 Hemostatic Powder Spray Market by Application
- 5.1 Hemostatic Powder Spray Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Hemostatic Powder Spray Sales by Application
- 5.2.1 Global Hemostatic Powder Spray Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hemostatic Powder Spray Sales by Application (2021-2032)
- 5.2.3 Global Hemostatic Powder Spray Sales Market Share by Application (2021-2032)
- 5.3 Global Hemostatic Powder Spray Revenue by Application
- 5.3.1 Global Hemostatic Powder Spray Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hemostatic Powder Spray Revenue by Application (2021-2032)
- 5.3.3 Global Hemostatic Powder Spray Revenue Market Share by Application (2021-2032)
6 Global Hemostatic Powder Spray Sales by Region
- 6.1 Global Hemostatic Powder Spray Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hemostatic Powder Spray Sales by Region (2021-2032)
- 6.2.1 Global Hemostatic Powder Spray Sales by Region (2021-2026)
- 6.2.2 Global Hemostatic Powder Spray Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hemostatic Powder Spray Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hemostatic Powder Spray Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hemostatic Powder Spray Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hemostatic Powder Spray Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hemostatic Powder Spray Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hemostatic Powder Spray Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hemostatic Powder Spray Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hemostatic Powder Spray Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hemostatic Powder Spray Revenue by Region
- 7.1 Global Hemostatic Powder Spray Revenue by Region
- 7.1.1 Global Hemostatic Powder Spray Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hemostatic Powder Spray Revenue by Region (2021-2026)
- 7.1.3 Global Hemostatic Powder Spray Revenue by Region (2027-2032)
- 7.1.4 Global Hemostatic Powder Spray Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hemostatic Powder Spray Revenue (2021-2032)
- 7.2.2 North America Hemostatic Powder Spray Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hemostatic Powder Spray Revenue (2021-2032)
- 7.3.2 Europe Hemostatic Powder Spray Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hemostatic Powder Spray Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hemostatic Powder Spray Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hemostatic Powder Spray Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hemostatic Powder Spray Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Company Information
- 8.1.2 Medtronic Business Overview
- 8.1.3 Medtronic Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Hemostatic Powder Spray Product Portfolio
- 8.1.5 Medtronic Recent Developments
- 8.2 QuikClot
- 8.2.1 QuikClot Company Information
- 8.2.2 QuikClot Business Overview
- 8.2.3 QuikClot Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 QuikClot Hemostatic Powder Spray Product Portfolio
- 8.2.5 QuikClot Recent Developments
- 8.3 Pfizer Inc.
- 8.3.1 Pfizer Inc. Company Information
- 8.3.2 Pfizer Inc. Business Overview
- 8.3.3 Pfizer Inc. Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Inc. Hemostatic Powder Spray Product Portfolio
- 8.3.5 Pfizer Inc. Recent Developments
- 8.4 Hemostasis, LLC
- 8.4.1 Hemostasis, LLC Company Information
- 8.4.2 Hemostasis, LLC Business Overview
- 8.4.3 Hemostasis, LLC Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Hemostasis, LLC Hemostatic Powder Spray Product Portfolio
- 8.4.5 Hemostasis, LLC Recent Developments
- 8.5 Ethicon Inc.
- 8.5.1 Ethicon Inc. Company Information
- 8.5.2 Ethicon Inc. Business Overview
- 8.5.3 Ethicon Inc. Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ethicon Inc. Hemostatic Powder Spray Product Portfolio
- 8.5.5 Ethicon Inc. Recent Developments
- 8.6 EndoClot Plus, Inc
- 8.6.1 EndoClot Plus, Inc Company Information
- 8.6.2 EndoClot Plus, Inc Business Overview
- 8.6.3 EndoClot Plus, Inc Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 EndoClot Plus, Inc Hemostatic Powder Spray Product Portfolio
- 8.6.5 EndoClot Plus, Inc Recent Developments
- 8.7 CryoLife, Inc.
- 8.7.1 CryoLife, Inc. Company Information
- 8.7.2 CryoLife, Inc. Business Overview
- 8.7.3 CryoLife, Inc. Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 CryoLife, Inc. Hemostatic Powder Spray Product Portfolio
- 8.7.5 CryoLife, Inc. Recent Developments
- 8.8 Cook Medical
- 8.8.1 Cook Medical Company Information
- 8.8.2 Cook Medical Business Overview
- 8.8.3 Cook Medical Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Cook Medical Hemostatic Powder Spray Product Portfolio
- 8.8.5 Cook Medical Recent Developments
- 8.9 BD
- 8.9.1 BD Company Information
- 8.9.2 BD Business Overview
- 8.9.3 BD Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 BD Hemostatic Powder Spray Product Portfolio
- 8.9.5 BD Recent Developments
- 8.10 Baxter International Inc.
- 8.10.1 Baxter International Inc. Company Information
- 8.10.2 Baxter International Inc. Business Overview
- 8.10.3 Baxter International Inc. Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Baxter International Inc. Hemostatic Powder Spray Product Portfolio
- 8.10.5 Baxter International Inc. Recent Developments
- 8.11 B. Braun
- 8.11.1 B. Braun Company Information
- 8.11.2 B. Braun Business Overview
- 8.11.3 B. Braun Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 B. Braun Hemostatic Powder Spray Product Portfolio
- 8.11.5 B. Braun Recent Developments
- 8.12 Advanced Medical Solutions Group
- 8.12.1 Advanced Medical Solutions Group Company Information
- 8.12.2 Advanced Medical Solutions Group Business Overview
- 8.12.3 Advanced Medical Solutions Group Hemostatic Powder Spray Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Advanced Medical Solutions Group Hemostatic Powder Spray Product Portfolio
- 8.12.5 Advanced Medical Solutions Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hemostatic Powder Spray Value Chain Analysis
- 9.1.1 Hemostatic Powder Spray Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hemostatic Powder Spray Production Mode & Process
- 9.2 Hemostatic Powder Spray Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hemostatic Powder Spray Distributors
- 9.2.3 Hemostatic Powder Spray Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst